Evidence map›Paper›PMID 25538156›Full record

ArticleCardiovascular research2015

Neuronal Na+ channel blockade suppresses arrhythmogenic diastolic Ca2+ release.

Przemysław B Radwański, Lucia Brunello, Rengasayee Veeraraghavan, Hsiang-Ting Ho, Qing Lou, Michael A Makara, Andriy E Belevych, Mircea Anghelescu, Silvia G Priori, Pompeo Volpe and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Selective activation of tetrodotoxin-sensitive sodium channels by AaH-II drives arrhythmogenic late Na+ current in the heart.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Tetrodotoxin-Sensitive Neuronal-Type NaJournal of the American Heart Association · 2020
    Article
  12. Super-Resolution Imaging Using a Novel High-Fidelity Antibody Reveals Close Association of the Neuronal Sodium Channel NaMicroscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada · 2020
    Article
  13. Article
  14. Article
  15. Tetrodotoxin-sensitive NaThe Journal of general physiology · 2018
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Species-Dependent Mechanisms of Cardiac Arrhythmia: A Cellular Focus.Clinical Medicine Insights. Cardiology · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Przemysław B RadwańskiDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA Division of Pharmacy Practice and Administration, College of Pharmacy, The Ohio State University, Columbus, OH, USA sandor.gyorke@osumc.edu przemyslaw.radwanski@osumc.edu.
Lucia BrunelloDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Rengasayee VeeraraghavanVTC Research Institute, School of Biomedical Engineering and Sciences, Virginia Tech, Roanoke, VA, USA.
Hsiang-Ting HoDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Qing LouDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Michael A MakaraDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Andriy E BelevychDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Mircea AnghelescuDepartment of Biological and Allied Health Sciences, Ohio Northern University, Ada, OH, USA.
Silvia G PrioriDivision of Cardiology and Molecular Cardiology, Maugeri Foundation-University of Pavia, Pavia, Italy.
Pompeo VolpeDepartment of Biomedical Sciences, University of Padova, Padova, Italy.
Thomas J HundDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA.
Paul M L JanssenDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Peter J MohlerDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.
John H B BridgeNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA.
Steven PoelzingVTC Research Institute, School of Biomedical Engineering and Sciences, Virginia Tech, Roanoke, VA, USA.
Sándor GyörkeDorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Room 507, Columbus, OH 43210, USA Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA sandor.gyorke@osumc.edu przemyslaw.radwanski@osumc.edu.
The Ohio State University · USThe Ohio State University Wexner Medical Center · USVirginia Tech · USOhio Northern University · USUniversity of Padua · ITUniversity of Pavia · ITUniversity of Utah · US

Funding

CONTROLLED AND UNCONTROLLABLE CALCIUM RELEASE IN HEARTR01HL063043 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI Sandor Gyorke · 1999 to 2026
$8.6M
Ryanodine Receptor Channels in Heart FailureR01HL074045 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GYORKE, SANDOR · 2003 to 2024
$8.2M
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitabilityR01HL083422 · NHLBI · VANDERBILT UNIVERSITY · PI MOHLER, PETER J. · 2006 to 2016
$3.8M
Role of ankyrin-B in human arrhythmiaR01HL084583 · NHLBI · UNIVERSITY OF IOWA · PI MOHLER, PETER J. · 2006 to 2015
$3.4M
Training in Congenital and Acquired Heart DiseaseT32HL098039 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GARG, VIDU, MOHLER, PETER J. · 2009 to 2019
$2.5M
EHD proteins in cardiac membrane protein targeting and remodelingR01HL114383 · NHLBI · OHIO STATE UNIVERSITY · PI BOYDEN, PENELOPE ALTMAN, MOHLER, PETER J. · 2013 to 2016
$2.1M
NHLBI NIH HHS HL063043NHLBI NIH HHS HL074045NHLBI NIH HHS HL083422NHLBI NIH HHS HL084583NHLBI NIH HHS HL098039-03NHLBI NIH HHS HL114383NHLBI NIH HHS R01 HL063043NHLBI NIH HHS R01 HL074045NHLBI NIH HHS R01 HL083422NHLBI NIH HHS R01 HL084583NHLBI NIH HHS R01 HL114383NHLBI NIH HHS T32 HL098039
6 · The paper itself

Abstract

aimsSudden death resulting from cardiac arrhythmias is the most common consequence of cardiac disease. Certain arrhythmias caused by abnormal impulse formation including catecholaminergic polymorphic ventricular tachycardia (CPVT) are associated with delayed afterdepolarizations resulting from diastolic Ca2+ release (DCR) from the sarcoplasmic reticulum (SR). Despite high response of CPVT to agents directly affecting Ca2+ cycling, the incidence of refractory cases is still significant. Surprisingly, these patients often respond to treatment with Na+ channel blockers. However, the relationship between Na+ influx and disturbances in Ca2+ handling immediately preceding arrhythmias in CPVT remains poorly understood and is the object of this study. METHODS AND

resultsWe performed optical Ca2+ and membrane potential imaging in ventricular myocytes and intact cardiac muscles as well as surface ECGs on a CPVT mouse model with a mutation in cardiac calsequestrin. We demonstrate that a subpopulation of Na+ channels (neuronal Na+ channels; nNav) colocalize with ryanodine receptor Ca2+ release channels (RyR2). Disruption of the crosstalk between nNav and RyR2 by nNav blockade with riluzole reduced and also desynchronized DCR in isolated cardiomyocytes and in intact cardiac tissue. Such desynchronization of DCR on cellular and tissue level translated into decreased arrhythmias in CPVT mice.

conclusionsThus, our study offers the first evidence that nNav contribute to arrhythmogenic DCR, thereby providing a conceptual basis for mechanism-based antiarrhythmic therapy.

Indexed as

AnimalsArrhythmias, CardiacCalciumCalsequestrinDiastoleDisease Models, AnimalMaleMembrane PotentialsMiceMice, Inbred C57BLMutationNeuronsRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumSodium Channel BlockersTachycardia, VentricularCalciumCalsequestrinRyanodine Receptor Calcium Release ChannelSodium Channel BlockersDiastolic Ca2+ releaseNeuronal Na+ channelsVentricular arrhythmias

Identifiers

PMID25538156
PMCPMC4375407
OpenAlexW2145445916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.